VBI Vaccines Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.93 |
Market Cap |
$93.06 M |
Shares Outstanding |
97.66 M |
Public Float |
78.16 M |
Address |
222 3rd Street Cambridge Massachusetts 02142 United States |
Employees | - |
Website | http://www.vbivaccines.com |
Updated | 07/08/2019 |
VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA. |